You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the United Kingdom.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Metastatic bone disease occurs when cancer metastasizes or moves into surrounding bone. Bone is invaded in 60-80% of patients with metastatic disease,1 most frequently among patients with primary tumours of the breast, prostate, and lung.2 The spine and pelvis are most commonly affected by bone tumours, but it’s possible for bone tumours to invade all areas of the body.3
Cancer that has moved to the surrounding bone can be extremely painful—making every day even more challenging. Metastatic bone disease can further affect quality of life by producing complications such as fractures and decreased mobility,4 along with mood changes such as depression and anxiety.5
1 IN 3
CANCER PATIENTS
Are left with inadequate treatment or undermanaged pain control because treatments like opioids, chemotherapy, and radiation therapy did not work for them.6
Your pain may be worse if you have failed or are not a candidate for conventional cancer therapies such as opioids, chemotherapy, and radiation therapy.7 If this sounds like you, you may be a candidate for radiofrequency (RF) ablation, a minimally invasive procedure designed to help treat cancer pain.
RF ablation may be a treatment option for you:
RF ablation uses alternating, low power current to generate heat during the procedure. The heat is delivered by a probe to the tumour to intentionally dry out and kill cancerous cells. OsteoCool™ RF ablation, a Medtronic RF ablation treatment, allows your doctor to deliver the ablation energy to the precise size and location of your tumour. During the procedure, pumped water circulates through the probes to control the temperature and help reduce damage to the surrounding healthy tissue.
If you’re living with cancer pain, you may think it is a natural part of the disease or its treatment and is something that must be endured. You may have decided that side effects from pain medications must be tolerated in exchange for pain control. But managing pain is possible.
Medtronic offers radiofrequency ablation, in addition to other therapies, to help treat cancer pain — so you can do more of the everyday things that make life special.
UNDERSTAND
THE PROCEDURE
Learn more about what to expect during the OsteoCool™ RF ablation procedure for cancer pain.
LEARN ABOUT OSTEOCOOLInformation on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.
Schulman, et al. Economic Burden of Metastatic Bone Disease. American Cancer Society, 2007.
Kurup AN, Callstrom MR. Ablation of Skeletal Metastases: Current Status. J Vasc Interv Radiol. 2010;21(8 Suppl): S242-S250.
Helmberger TK and Hoffman RT. Bone. In: Vogl TJ, Helmberger TK, Mack MG, Reiser, MF. Percutaneous Tumour Ablation in Medical Radiology. Springer, 2008; 243.
Goetz, et al. Percutaneous Image-Guided Radiofrequency Ablation of Painful Metastases Involving Bone: A Multicenter Study. J Clin Oncol. 2004;22(2):300–306.
Spiegel D, et al. Pain and depression in patients with cancer. Cancer. 1994;74:2570-2578.
Anselmetti, et al. Treatment of Extraspinal Painful Bone Metastases with Percutaneous Cementoplasty: A Prospective Study of 50 Patients. Cardiovasc Intervent Radiol. 2008;31:1165-1173.
Sabharwal T, Katsanos K, Buy X, Gangi A. Image-Guided Ablation Therapy of Bone Tumours. Semin Ultrasound CT MRI. 2009;(2):78-90.
Di Staso M, Zugaro L, Gravina GL, Bonfili P, Marampon F, Di Nicola L, Conchiglia A, Ventura L, Franzese P, Gallucci M, Masciocchi C, Tombolini V. A feasibility study of percutaneous Radiofrequency Ablation followed by Radiotherapy in the management of painful osteolytic bone metastases. Eur Radiol. 2011 Sep;21(9):2004-10. doi: 10.1007/s00330-011-2133-3. Epub 2011 May 1. PMID: 21533865.
Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: A multicenter study. J Clin Oncol 2004; 22: 300-306